Science Friday

CRISPR-Based Sickle Cell Treatment | Pain Tolerance From Neanderthals

11.03.2023 - By Science Friday and WNYC StudiosPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

If given final approval by the FDA, this sickle-cell treatment would be the first to use gene-editing CRISPR technology on humans. Also, gene variants inherited from Neanderthals can impact pain tolerance in modern humans.

More episodes from Science Friday